The Evolution of Shadow
Ever the upstart and revolutionary, Yamatetsu Corporation sprang on the scene in 2041 to everyone’s dismay. These punks were determined to get themselves a seat on the Corporate Court and weren’t taking any negative answers—how dare they? At least that’s what other corps kept saying until Yamatetsu managed it in 2042, hauling themselves up to AAA status and thumbing their noses at the naysayers. They’ve continually had to oust the deadwood, those who would hold the company back, but otherwise have consistently attempted to remain at the forefront of technology, recently delving into many genetic endeavors as “Evo”.
Evo’s focus in their genetic research has been primarily health related. They have been trying to modify the human genome to make its bearers resistant to heart disease, cancer, psychological dysfunctions, and many other hereditary and communicable diseases and syndromes.